Buscopan 0.1 % Syrup 5 mg Syrup.
PDF Leaflet Revision Date: 13 April 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of gastrointestinal spasm.
Dosage (summary)
Adults: 20 mL four times daily; Children: varies by age.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding.
Key Drug Interactions
- Anticholinergics
- Dopamine antagonists
- Beta-adrenergic medicines
Contraindications
- Hypersensitivity
- Myasthenia gravis
- Narrow angle glaucoma
- Tachycardia
Common side effects
- Dry mouth
- Tachycardia
- Skin reactions
Counselling Points
- Do not exceed recommended dose
- Seek medical advice for severe abdominal pain
Serious warnings
- Risk of anticholinergic complications
- Caution in glaucoma patients
Important Disclaimer
The Buscopan 0.1 % Syrup 5 mg Syrup. professional information leaflet below is the property of Sanofi-Aventis South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
